Afuco™ Anti-Human IFNG ADCC Recombinant Antibody, ADCC Enhanced (AFC-365CL) (CAT#: AFC-365CL)
Anti-IFNG ADCC Enhanced Antibody (NI-0501) is an ADCC enhanced antibody produced by our Afuco™ platform. NI-0501 is a fully human monoclonal antibody that neutralizes interferon gamma, a cell-signaling protein believed to play a pivotal role in the development of HLH. In the ongoing Phase II study, NI-0501 was initially administered to patients showing unsatisfactory response or intolerance to conventional therapies including chemotherapy, immune-suppressive medicines, and immune-depleting drugs. The approved amendment to the protocol allows NI-0501 to be administered to patients as a first-line treatment before any other intervention.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

(Endothelial cells
Staining: Medium
Intensity: Moderate
Quantity:>75%
Location: Cytoplasmic/membranous
Glandular cells
Staining: Medium
Intensity: Moderate
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/10344/26961_A_8_3.jpg

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000111537-IFNG

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000111537-IFNG
Specifications
- Host Species
- Human
- Derivation
- Human
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Related Disease
- Autoimmune Diseases; Inflammatory Diseases
Product Property
- Purity
- >98% by SDS-PAGE and HPLC analysis
- Storage
- 4°C or -20°C, avoid repeated freezing and thawing.
Target
- Alternative Names
- IFNG; interferon, gamma; IFG; IFI; interferon gamma; IFN-gamma; immune interferon
- Gene ID
- 3458
- UniProt ID
- P01579
Related Resources
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "IFNG"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABL-090 | Recombinant Anti-human IFNG VHH Single Domain Antibody | WB, ELISA, IHC, FC, FuncS | Llama VHH |
TAB-140CT | Anti-Human IFN-γ Single Domain Antibody (TAB-140CT), Research Grade Biosimilar | ELISA | Single domain antibody |
TAB-141CT | Anti-Human IFN-γ Single Domain Antibody (TAB-141CT), Research Grade Biosimilar | ELISA | Single domain antibody |
TAB-142CT | Anti-Human IFN-γ Single Domain Antibody (TAB-142CT), Research Grade Biosimilar | ELISA | Single domain antibody |
TAB-143CT | Anti-Human IFN-γ Single Domain Antibody (TAB-143CT), Research Grade Biosimilar | ELISA | Single domain antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-365CL. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: Neut, ELISA, IF, IP, FuncS, FC, IHC
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: ELISA, IP, WB, IHC, IF, FuncS
Application: IB, ELISA, FC, FuncS
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: Neut, ELISA, WB, SPR, IF, EM
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.